
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement
Matthew McCallum, Nadine Czudnochowski, Laura E. Rosen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 29
Matthew McCallum, Nadine Czudnochowski, Laura E. Rosen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex
Dhiraj Mannar, James W. Saville, Xing Zhu, et al.
Science (2022) Vol. 375, Iss. 6582, pp. 760-764
Open Access | Times Cited: 608
Dhiraj Mannar, James W. Saville, Xing Zhu, et al.
Science (2022) Vol. 375, Iss. 6582, pp. 760-764
Open Access | Times Cited: 608
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron
Huiping Shuai, Jasper Fuk‐Woo Chan, Bingjie Hu, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 693-699
Open Access | Times Cited: 608
Huiping Shuai, Jasper Fuk‐Woo Chan, Bingjie Hu, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 693-699
Open Access | Times Cited: 608
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
Peter Halfmann, Shun Iida, Kiyoko Iwatsuki‐Horimoto, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 687-692
Open Access | Times Cited: 589
Peter Halfmann, Shun Iida, Kiyoko Iwatsuki‐Horimoto, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 687-692
Open Access | Times Cited: 589
Understanding T cell responses to COVID-19 is essential for informing public health strategies
Santosha A. Vardhana, Lance Baldo, William G. Morice, et al.
Science Immunology (2022) Vol. 7, Iss. 71
Open Access | Times Cited: 118
Santosha A. Vardhana, Lance Baldo, William G. Morice, et al.
Science Immunology (2022) Vol. 7, Iss. 71
Open Access | Times Cited: 118
SARS-CoV-2 Omicron spike mediated immune escape and tropism shift
Bo Meng, Isabella A. T. M. Ferreira, Adam Abdullahi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 57
Bo Meng, Isabella A. T. M. Ferreira, Adam Abdullahi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 57
SARS-CoV-2 Omicron spike mediated immune escape and tropism shift
Ravindra K. Gupta
Research Square (Research Square) (2022)
Open Access | Times Cited: 47
Ravindra K. Gupta
Research Square (Research Square) (2022)
Open Access | Times Cited: 47
Selection analysis identifies unusual clustered mutational changes in Omicron lineage BA.1 that likely impact Spike function
Darren P. Martin, Spyros Lytras, Alexander G. Lucaci, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 43
Darren P. Martin, Spyros Lytras, Alexander G. Lucaci, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 43
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Young‐Jun Park, Dora Pinto, Alexandra C. Walls, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 37
Young‐Jun Park, Dora Pinto, Alexandra C. Walls, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 37
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants
Amin Addetia, Luca Piccoli, James Brett Case, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 30
Amin Addetia, Luca Piccoli, James Brett Case, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 30
Human coronavirus HKU1 recognition of the TMPRSS2 host receptor
Matthew McCallum, Young‐Jun Park, Cameron Stewart, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7
Matthew McCallum, Young‐Jun Park, Cameron Stewart, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7
Association Between Vaccination Coverage Disparity and the Dynamics of the COVID-19 Delta and Omicron Waves in the US
Diego F. Cuadros, Claudia M. Moreno, Godfrey Musuka, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 34
Diego F. Cuadros, Claudia M. Moreno, Godfrey Musuka, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 34
Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution
Tyler N. Starr, Allison J. Greaney, William W. Hannon, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 27
Tyler N. Starr, Allison J. Greaney, William W. Hannon, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 27
Impact of vaccination on SARS-CoV-2 evolution and immune escape variants
Deepak Jena, Arup Ghosh, Atimukta Jha, et al.
Vaccine (2024) Vol. 42, Iss. 21, pp. 126153-126153
Closed Access | Times Cited: 3
Deepak Jena, Arup Ghosh, Atimukta Jha, et al.
Vaccine (2024) Vol. 42, Iss. 21, pp. 126153-126153
Closed Access | Times Cited: 3
Molecular basis of SARS-CoV-2 Omicron variant receptor engagement and antibody evasion and neutralization
Hong Qin, Wenyu Han, Jiawei Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 15
Hong Qin, Wenyu Han, Jiawei Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 15
Antibody escape and cryptic cross-domain stabilization in the SARS-CoV-2 Omicron spike protein
Kamyab Javanmardi, Thomas H. Segall-Shapiro, Chia‐Wei Chou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 9
Kamyab Javanmardi, Thomas H. Segall-Shapiro, Chia‐Wei Chou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 9
Designed miniproteins potently inhibit and protect against MERS-CoV
Robert J. Ragotte, M. Alejandra Tortorici, Nicholas Catanzaro, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Robert J. Ragotte, M. Alejandra Tortorici, Nicholas Catanzaro, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
Jun Zhang, Yongfei Cai, Christy L. Lavine, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 8
Jun Zhang, Yongfei Cai, Christy L. Lavine, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 8
Genome-first detection of emerging resistance to novel therapeutic agents for SARS-CoV-2
Manon Ragonnet‐Cronin, Rungtiwa Nutalai, Jiandong Huo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Manon Ragonnet‐Cronin, Rungtiwa Nutalai, Jiandong Huo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Broad receptor tropism and immunogenicity of a clade 3 sarbecovirus
Jimin Lee, Samantha K. Zepeda, Young‐Jun Park, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Jimin Lee, Samantha K. Zepeda, Young‐Jun Park, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
A broadly generalizable stabilization strategy for sarbecovirus fusion machinery vaccines
Jimin Lee, Cameron Stewart, Alexandra Schaefer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Jimin Lee, Cameron Stewart, Alexandra Schaefer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response
Lyudmila Shalamova, Ulrike Felgenhauer, Andreas R. Schaubmar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Lyudmila Shalamova, Ulrike Felgenhauer, Andreas R. Schaubmar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Differences between Omicron SARS-CoV-2 RBD and other variants in their ability to interact with cell receptors and monoclonal antibodies
Carolina Corrêa Giron, Aatto Laaksonen, Fernando Luís Barroso da Silva
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Carolina Corrêa Giron, Aatto Laaksonen, Fernando Luís Barroso da Silva
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants
Wenjuan Du, Daniel L. Hurdiss, Dubravka Drabek, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Wenjuan Du, Daniel L. Hurdiss, Dubravka Drabek, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Structural and functional characteristics of SARS-CoV-2 Omicron subvariant BA.2 spike
Jun Zhang, Weichun Tang, Hailong Gao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Jun Zhang, Weichun Tang, Hailong Gao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Across-the-board review on Omicron SARS-CoV-2 variant
Rufaida Wasim, Sumaiya, Asad Maqbool Ahmad
Inflammopharmacology (2024)
Closed Access
Rufaida Wasim, Sumaiya, Asad Maqbool Ahmad
Inflammopharmacology (2024)
Closed Access